MRI-guided radiotherapy of the SK-N-SH neuroblastoma xenograft model using a small animal radiation research platform
<h4>Objective</h4> <p>Neuroblastoma has one of the lowest survival rates of all childhood cancers despite the use of intensive treatment regimens. Preclinical models of neuroblastoma are essential for testing new multimodality protocols, including those that involve radiotherapy (...
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Journal article |
Published: |
British Institute of Radiology
2016
|
_version_ | 1826271692499976192 |
---|---|
author | Vallis, K Corroyer-Dulmont, A Falzone, N Kersemans, V Thompson, J Hill, M Allen, P Beech, J Gilchrist, S Vojnovic, B Kinchesh, P Gaze, M Tullis, I Smart, S |
author_facet | Vallis, K Corroyer-Dulmont, A Falzone, N Kersemans, V Thompson, J Hill, M Allen, P Beech, J Gilchrist, S Vojnovic, B Kinchesh, P Gaze, M Tullis, I Smart, S |
author_sort | Vallis, K |
collection | OXFORD |
description | <h4>Objective</h4> <p>Neuroblastoma has one of the lowest survival rates of all childhood cancers despite the use of intensive treatment regimens. Preclinical models of neuroblastoma are essential for testing new multimodality protocols, including those that involve radiotherapy (RT). The aim of this study was to develop a robust method for RT planning and tumour response monitoring based on combined MRI and cone beam CT (CBCT) imaging and to apply it to a widely studied mouse xenograft model of neuroblastoma, SK-N-SH.</p> <h4>Methods</h4> <p>As part of a tumour growth inhibition study, SK-N-SH xenografts were generated in BALB/c nu/nu mice. Mice (n=8) were placed in a printed MR and CT-compatible plastic cradle, imaged using a 4.7T MRI scanner and then transferred to a small animal radiation research platform (SARRP) irradiator with on-board CBCT. MRI/CBCT co-registration was performed to enable RT planning using the soft tissue contrast afforded by MRI prior to delivery of RT (5 Gy). Tumour response was assessed by serial MRI and calliper measurements.</p> <h4>Results</h4> <p>SK-N-SH xenografts formed soft, deformable tumours that could not be differentiated from surrounding normal tissues using CBCT. MR images, which allowed clear delineation of tumours, were successfully co-registered with CBCT images, allowing conformal RT to be delivered. MRI measurements of tumour volume 4 days after RT correlated strongly with length of survival time.</p> <h4>Conclusion</h4> <p>MR imaging allowed precision RT of SK-N-SH tumours and provided an accurate means of measuring tumour response.</p> |
first_indexed | 2024-03-06T22:00:41Z |
format | Journal article |
id | oxford-uuid:4e7be963-2fcd-4978-b5f5-a5ebe9180714 |
institution | University of Oxford |
last_indexed | 2024-03-06T22:00:41Z |
publishDate | 2016 |
publisher | British Institute of Radiology |
record_format | dspace |
spelling | oxford-uuid:4e7be963-2fcd-4978-b5f5-a5ebe91807142022-03-26T16:01:27ZMRI-guided radiotherapy of the SK-N-SH neuroblastoma xenograft model using a small animal radiation research platformJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:4e7be963-2fcd-4978-b5f5-a5ebe9180714Symplectic Elements at OxfordBritish Institute of Radiology2016Vallis, KCorroyer-Dulmont, AFalzone, NKersemans, VThompson, JHill, MAllen, PBeech, JGilchrist, SVojnovic, BKinchesh, PGaze, MTullis, ISmart, S <h4>Objective</h4> <p>Neuroblastoma has one of the lowest survival rates of all childhood cancers despite the use of intensive treatment regimens. Preclinical models of neuroblastoma are essential for testing new multimodality protocols, including those that involve radiotherapy (RT). The aim of this study was to develop a robust method for RT planning and tumour response monitoring based on combined MRI and cone beam CT (CBCT) imaging and to apply it to a widely studied mouse xenograft model of neuroblastoma, SK-N-SH.</p> <h4>Methods</h4> <p>As part of a tumour growth inhibition study, SK-N-SH xenografts were generated in BALB/c nu/nu mice. Mice (n=8) were placed in a printed MR and CT-compatible plastic cradle, imaged using a 4.7T MRI scanner and then transferred to a small animal radiation research platform (SARRP) irradiator with on-board CBCT. MRI/CBCT co-registration was performed to enable RT planning using the soft tissue contrast afforded by MRI prior to delivery of RT (5 Gy). Tumour response was assessed by serial MRI and calliper measurements.</p> <h4>Results</h4> <p>SK-N-SH xenografts formed soft, deformable tumours that could not be differentiated from surrounding normal tissues using CBCT. MR images, which allowed clear delineation of tumours, were successfully co-registered with CBCT images, allowing conformal RT to be delivered. MRI measurements of tumour volume 4 days after RT correlated strongly with length of survival time.</p> <h4>Conclusion</h4> <p>MR imaging allowed precision RT of SK-N-SH tumours and provided an accurate means of measuring tumour response.</p> |
spellingShingle | Vallis, K Corroyer-Dulmont, A Falzone, N Kersemans, V Thompson, J Hill, M Allen, P Beech, J Gilchrist, S Vojnovic, B Kinchesh, P Gaze, M Tullis, I Smart, S MRI-guided radiotherapy of the SK-N-SH neuroblastoma xenograft model using a small animal radiation research platform |
title | MRI-guided radiotherapy of the SK-N-SH neuroblastoma xenograft model using a small animal radiation research platform |
title_full | MRI-guided radiotherapy of the SK-N-SH neuroblastoma xenograft model using a small animal radiation research platform |
title_fullStr | MRI-guided radiotherapy of the SK-N-SH neuroblastoma xenograft model using a small animal radiation research platform |
title_full_unstemmed | MRI-guided radiotherapy of the SK-N-SH neuroblastoma xenograft model using a small animal radiation research platform |
title_short | MRI-guided radiotherapy of the SK-N-SH neuroblastoma xenograft model using a small animal radiation research platform |
title_sort | mri guided radiotherapy of the sk n sh neuroblastoma xenograft model using a small animal radiation research platform |
work_keys_str_mv | AT vallisk mriguidedradiotherapyofthesknshneuroblastomaxenograftmodelusingasmallanimalradiationresearchplatform AT corroyerdulmonta mriguidedradiotherapyofthesknshneuroblastomaxenograftmodelusingasmallanimalradiationresearchplatform AT falzonen mriguidedradiotherapyofthesknshneuroblastomaxenograftmodelusingasmallanimalradiationresearchplatform AT kersemansv mriguidedradiotherapyofthesknshneuroblastomaxenograftmodelusingasmallanimalradiationresearchplatform AT thompsonj mriguidedradiotherapyofthesknshneuroblastomaxenograftmodelusingasmallanimalradiationresearchplatform AT hillm mriguidedradiotherapyofthesknshneuroblastomaxenograftmodelusingasmallanimalradiationresearchplatform AT allenp mriguidedradiotherapyofthesknshneuroblastomaxenograftmodelusingasmallanimalradiationresearchplatform AT beechj mriguidedradiotherapyofthesknshneuroblastomaxenograftmodelusingasmallanimalradiationresearchplatform AT gilchrists mriguidedradiotherapyofthesknshneuroblastomaxenograftmodelusingasmallanimalradiationresearchplatform AT vojnovicb mriguidedradiotherapyofthesknshneuroblastomaxenograftmodelusingasmallanimalradiationresearchplatform AT kincheshp mriguidedradiotherapyofthesknshneuroblastomaxenograftmodelusingasmallanimalradiationresearchplatform AT gazem mriguidedradiotherapyofthesknshneuroblastomaxenograftmodelusingasmallanimalradiationresearchplatform AT tullisi mriguidedradiotherapyofthesknshneuroblastomaxenograftmodelusingasmallanimalradiationresearchplatform AT smarts mriguidedradiotherapyofthesknshneuroblastomaxenograftmodelusingasmallanimalradiationresearchplatform |